Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|8|613-635

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.8, 2001-05, pp. : 613-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption

By Tamura T.   Shirai T.   Kosaka N.   Ohmori K.   Takafumi N.  

European Journal of Pharmacology, Vol. 448, Iss. 1, 2002-07 ,pp. : 81-87

Elsevier

Access to resources Recommend Favorite

Osteoprotegerin reduces bone cancer pain

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Phenothiazines are Potent Inhibitors of Osteoclastic Bone Resorption

By Hall T.J.   Nyugen H.   Schaeublin M.   Michalsky M.   Missbach M.  

General Pharmacology, Vol. 27, Iss. 5, 1996-07 ,pp. : 845-848

Elsevier

Access to resources Recommend Favorite

-Alanyl-L-Histidinato Zinc and Bone Resorption

By Yamaguchi M.  

General Pharmacology, Vol. 26, Iss. 6, 1995-10 ,pp. : 1179-1183

Elsevier

Access to resources Recommend Favorite

Regulation of bone resorption and formation by purines and pyrimidines

By Hoebertz A.   Arnett T.R.   Burnstock G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 6, 2003-06 ,pp. : 290-297

Elsevier

Access to resources Recommend Favorite